Leadership & Pay ·
Xeris Biopharma Holdings, Inc. expanded its Board of Directors to eight members and appointed Nerissa Kreher, M.D., as…
XERSXeris Biopharma Holdings, Inc.
Xeris Biopharma Holdings, Inc. expanded its Board of Directors to eight members and appointed Nerissa Kreher, M.D., as a Class III director, effective July 1, 2026. Dr. Kreher's initial equity award has a combined aggregate grant date fair value of approximately $450,000. Additionally, the Board appointed John Shannon, the Company's CEO, to serve as Chairperson of the Board, effective July 1, 2026, and designated Marla S. Persky as Lead Independent Director. Xeris Biopharma Holdings, Inc. is a biopharmaceutical company that develops and commercializes biopharmaceutical products.